Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.150
+0.040 (1.90%)
Dec 5, 2025, 4:00 PM EST - Market closed
Entera Bio Employees
As of December 31, 2024, Entera Bio had 20 total employees, including 18 full-time and 2 part-time employees. The number of employees increased by 2 or 11.11% compared to the previous year.
Employees
20
Change (1Y)
2
Growth (1Y)
11.11%
Revenue / Employee
$6,200
Profits / Employee
-$539,050
Market Cap
98.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENTX News
- 17 days ago - Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women - GlobeNewsWire
- 7 weeks ago - Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting - GlobeNewsWire
- 4 months ago - Entera Bio Beats Q2 EPS Estimates - The Motley Fool
- 4 months ago - Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 4 months ago - Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis - GlobeNewsWire
- 7 months ago - Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 9 months ago - Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire